In an era marked by the opioid crisis, the need for reliable non-opioid pain management and regenerative health solutions has never been more urgent. Consequently, the annunciation of a national group purchasing agreement between Pacira BioSciences, Inc. and Premier, Inc. bears that significance. Pacira, a pioneering entity in the pharmaceutical industry, has secured this breakthrough contract which transposes its commitment to non-opioid pain management into tangible form.
Under this agreement, effective from January 1, 2024, Premier members are en
Comments